IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·
← Leaderboard
SNN
Ticker

SNN

Congressional Trades
4
by 1 members
Ticker Intelligence Brief

Who in Congress traded SNN, when, and what happened after?

A ticker-first view for retail/data users: latest disclosure, largest range, disclosure lag, party flow, contracts, lobbying, and source-linked receipts.

Latest receipt
Lisa McClain
SELL · 2025-06-17
Largest range
$1K – $15K
Lisa McClain
Slowest filing
66d
Lisa McClain
Best vs SPY
-4.7%
Lisa McClain
Buys
2
50%
Sells
2
50%
Total Volume
$32K
midpoint
Unique Traders
1
members

Party Breakdown

Democrats0 · 0%
Republicans4 · 100%

💼 Lobbying Filings

all →
  • 2026-04-20$420K
    SMITH & NEPHEW INC.
    Medicare physician fee schedule and Medicare hospital outpatient rule, issues related to skin substitutes. Issues related to Medicare local coverage determinations for skin substitutes. H.R. 5768 / S. 2561, Skin Substitute Access and Payment Reform Act of 2025. H.R. 6852 Advanced Wound Care and Regenerative Medicine Access and Reform Act. Issues related to APNRM on Ensuring Safety Through Domestic Security With Made in America Personal Protective Equipment (PPE) and Essential Medicine Procurement by Medicare Participating Hospitals. Issues related to section 899 of the One Big Beautiful Bill Act, H.R.1. Issues related to tariffs. Issues related to the USMCA trade agreement. Educate key government stakeholders on Smith+Nephew products applicable to the military and seek support for appropriations requests.
  • 2026-04-15$60K
    SMITH & NEPHEW INC.
    Issues related to disposable negative pressure wound therapy. Issues related to payment for skin substitutes wound treatments. Issues related to coding and payment rates for tympanostomy and other procedures involving pediatric medical devices. Monitored the implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to drug pricing. Monitored issues related to payments for medical devices. Issues related to Most Favored Nation drug pricing. Monitored implementation of H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to corporate and international taxes. Monitor OECD negotiations related to Pillar II global minimum tax. Monitored issues related to price transparency. Monitored issues related to tariffs.
  • 2026-04-15$40K
    SMITH & NEPHEW
    Educated key government stakeholders on Smith+Nephew products applicable to the military and support appropriations and authorization requests. Educated key government stakeholders on Smith+Nephew products applicable to the military and support appropriations and authorization requests. Educated key government stakeholders on Smith+Nephew products applicable to the military and support appropriations and authorization requests.
  • 2026-01-20$340K
    SMITH & NEPHEW INC.
    Medicare physician fee schedule and Medicare hospital outpatient rule, issues related to skin substitutes. Medicare physician fee schedule issues related to pediatric tympanostomies. H.R. 1931 / S. 249, Access to Pediatric Technologies Act of 2025. H.R. 5768 / S. 2561, Skin Substitute Access and Payment Reform Act of 2025. Issues related to section 899 of the One Big Beautiful Bill Act, H.R.1. Issues related to tariffs. Educate key government stakeholders on Smith+Nephew products applicable to the military and seek support for appropriations requests.
  • 2026-01-20$60K
    SMITH & NEPHEW INC.
    Monitored issues related to tariffs. Issues related to disposable negative pressure wound therapy. Issues related to payment for skin substitutes wound treatments. Issues related to coding and payment rates for tympanostomy and other procedures involving pediatric medical devices. S. 249/H.R. 1931, Access to Pediatric Technologies Act of 2025. Monitored the implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to drug pricing. Monitored issues related to pass-through payments for medical devices. Issues related to Most Favored Nation drug pricing. Monitor implementation of H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to corporate and international taxes. Monitor OECD negotiations related to Pillar II global minimum tax. H.R. 591, Defending American Jobs and Investment Act, and H.R. 2423, Unfair Tax Prevention Act, as they relate to multinational corporations. Monitored issues related to price transparency.
  • 2026-01-12$10K
    SMITH & NEPHEW
    Educated key government stakeholders on Smith+Nephew products applicable to the military and support appropriations and authorization requests. Educated key government stakeholders on Smith+Nephew products applicable to the military and support appropriations and authorization requests. Educated key government stakeholders on Smith+Nephew products applicable to the military and support appropriations and authorization requests.
  • 2025-10-20$350K
    SMITH & NEPHEW INC.
    Issues related to tariffs. Educate key government stakeholders on Smith+Nephew products applicable to the military and seek support for appropriations requests. Medicare physician fee schedule, Medicare hospital outpatient rule, and Medicare Administrative Contractor policies, issues related to skin substitutes. Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to pediatric tympanostomies. H.R. 1931 / S.249, Access to Pediatric Technologies Act of 2025. S. 2561, Skin Substitute Access and Payment Reform Act of 2025. Issues related to the base erosion and anti-abuse tax. Section 899 of the One Big Beautiful Bill Act, H.R.1. Issues related to medical device sterilization and the use of ethylene oxide for sterilization under EPAs proposed regulations for the National Emission Standards for Hazardous Air Pollutants and the Federal Insecticide, Fungicide, and Rodenticide Act.
  • 2025-10-15$10K
    SMITH & NEPHEW
    Educated key government stakeholders on Smith+Nephew products applicable to the military and support appropriations and authorization requests. Educated key government stakeholders on Smith+Nephew products applicable to the military and support appropriations and authorization requests. Educated key government stakeholders on Smith+Nephew products applicable to the military and support appropriations and authorization requests.
  • 2025-10-12$60K
    SMITH & NEPHEW INC.
    Issues related to disposable negative pressure wound therapy. Issues related to payment for skin substitutes wound treatments. Issues related to coding and payment rates for tympanostomy and other procedures involving pediatric medical devices. S. 249/H.R. 1931, Access to Pediatric Technologies Act of 2025. Monitored the implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to drug pricing. Monitored issues related to pass-through payments for medical devices. Monitored H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to Medicaid. Issues related to Most Favored Nation drug pricing. H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to corporate and international taxes. Monitored issues related to price transparency. Monitored issues related to tariffs.
  • 2025-07-21$370K
    SMITH & NEPHEW INC.
    Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to skin substitutes. Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to pediatric tympanostomies. H.R. 1931 / S.249, Access to Pediatric Technologies Act of 2025. Issues related to the base erosion and anti-abuse tax. Section 899 of the One Big Beautiful Bill Act, H.R.1. Educated key government stakeholders on Smith+Nephew products applicable to the military and support appropriations requests. Issues related to medical device sterilization and the use of ethylene oxide for sterilization under EPAs proposed regulations for the National Emission Standards for Hazardous Air Pollutants and the Federal Insecticide, Fungicide, and Rodenticide Act. Issues related to tariffs.

Congressional Momentum

buy vs. sell pressureNEUTRAL

Score 0–100: above 50 = net buying pressure, below 50 = net selling. Signal based on last 90 days.

Last 30 Days
No trades
Last 90 Days
No trades
All-Time
50
2 buys4 total2 sells
$16K buys · $16K sells
Cumulative Net Position (buy vol − sell vol)
+$0
2025-064 trades plotted2025-06

All Disclosed Trades

DateMemberActionAmountFiling DelayReceipt
2025-06-17RLisa McClainSELL$1K – $15K58dreceipt →
2025-06-09RLisa McClainBUY$1K – $15K66dreceipt →
2025-06-17RLisa McClainSELL$1K – $15K57dreceipt →
2025-06-09RLisa McClainBUY$1K – $15K65dreceipt →